• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Events

35th ISCTRC Conference

23-27 September 2019

Abuja, Nigeria

The International Scientific Council for Trypanosomiasis Research and Control (ISCTRC) 35th edition aims to discuss the impact of African trypanosomiasis on human and animal health, sustainable agriculture, and rural development in the face of challenges to sustainable investment in AAT control and HAT elimination.

Sessions

Diagnostic and treatment I

Date: Tuesday, 24 September 2019
Time: 14:30 – 16:00

Performance of diagnostic algorithms based on rapid diagnostic tests to detect sleeping sickness in the Democratic Republic of Congo
Makabuza Mukabela Jacquies
Difficulties conducting sensitive tests for the diagnosis of human African trypanosomiasis in the Democratic Republic of Congo
Ilunga J*, Hasker E, and Mwamba Miaka E
Strengthening diagnostic documentation procedures in clinical trials to develop new therapeutic tools in human African trypanosomiasis
Dinanga J*, Tshimanga D, Ngolo D, Cire Thiam M, Mutombo W, Rembry S, Perdrieu C, Pretre A, Delhomme S, Valverde O, Tarral A, Strub-Wourgaft N
Description of a quality Assurance system for the biological diagnosis of HAT in the National Programme for the control of HAT in DRC
Mutangala W*, Mwamba E, Kwete J, Basha M, Bawota J, Mumba D, Pyana P, Inocencio da Luz R, Büscher P, Boelaert M
Sensitivity of serological tests for Trypanosoma brucei gambiense in detecting antibodies in livestock, and correlate with tsetse fly infestation in a human african trypanosomiasis endemic foci in delta state, Nigeria
Dede PM*, Ajakaiye JJ, Wayo B, David K, Yusuf AB, Baba U, Ezebuiro CO, Edache C, Ishaq AR, N’dungu J
Evolution of the nutritional status of children included in the DNDi HAT FEX006 study in the Democratic Republic of Congo (DRC), between the time of diagnosis and the end of the 18-month follow-up
Mudji JE*, Ngolo D, Mutombo W, Valverde O

Epidemiology and control I

Date: Wednesday, 25 September 2019
Time: 8:15 – 10:00

Risk of post-transfusion transmission of human african trypanosomiasis in the city of Mbuji-Mayi in the Democratic Republic of Congo (March 2003 – December 2017)
Milomba B*, Ilunga J, Ilunga M, Mpoyi D, Kazumba D, Tshimungu F
Risk of resurgence of HAT in low-prevalence conflict areas: Case of Eastern Kasai Province in the DRC from 2013 to 2018
Rashidi S*, MBo F, Miaka E
The HAT Atlas: a GIS-based system to plan control activities and monitor progress in HAT elimination
Grout L*, Paone M, Priotto G, Cecchi G, Ebeja AK, Diarra A, Franco JR
Passive surveillance for sustainable elimination of Human African Trypanosomiasis in Central Kongo Province, DRC
Jacquies Makabuza Mukabela
Enhanced passive screening for HAT in Angola – progress towards elimination.
Makana DP*, Amadeu D, Kayembe S, Bessell P, Josenando, Machado C, Ndung’u J
Human african trypanosomiasis: constraints to effective reports in Nigeria
Olaleye OO*, Aluma LA, Gbadamosi FI, Abdulkadir AD
Human African trypanosomiasis (HAT): decreasing prevalence, increasing cost per case detected, the challenge of active case detection for disease elimination
Olaf Valverde, T.b. Rhodesiense HAT Leader, DNDi, Switzerland

*Presenting author

More information:

  • Website

Other events

Loading...
20 May 2025

Geneva, Switzerland

Strengthening the global ecosystem for paediatric medicines: leadership, collaboration, and impact

21 May 2025

Geneva, Switzerland

Scaling impact: Climate & health solutions that drive change

7-10 May 2025

Amsterdam, The Netherlands

EASL Congress 2025

20-25 May 2025

Iguaçu Falls, Brazil

22nd ISHAM Congress

See all

Stay connected

Get our latest news, personal stories, research articles, and job opportunities. 

Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License